Author

A. Schwarzer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Anantha· 1 shared A. Cooper· 1 shared A. Dorrie· 1 shared A. Kotlyarov· 1 shared A. Schambach· 1 shared D. Weinstock· 1 shared J. Levine· 1 shared L. Stiles· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Anantha

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting aggressive B-cell lymphomas through pharmacological activation of the mitochondrial protease OMA1

A. Schwarzer, M. Oliveira, M.-J. Kleppa, S. D. Slattery, A. Anantha, A. Cooper, M. Hannink, A. Schambach, A. Dorrie, A. Kotlyarov, M. Gaestel, T. Hembrough, J. Levine, M. Luther, M. Stocum, , M. J. Kostura

This study identifies OMA1 activators that induce apoptosis in DLBCL cells via the ATF4-ISR pathway, showing efficacy in preclinical models.

bioRxiv · Jun 12, 2022Cancer Biology